Research programme: hepatitis B vaccines - Janseen Pharmaceuticals/Ichor Medical SystemsAlternative Names: DNA vaccines - Janseen Pharmaceuticals/Ichor Medical Systems; Electroporation-mediated DNA vaccines - Janseen Pharmaceuticals/Ichor Medical Systems
Latest Information Update: 08 May 2015
At a glance
- Originator Janssen Pharmaceuticals
- Developer Ichor Medical Systems; Janssen Pharmaceuticals
- Class DNA vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Hepatitis B